Gordon Chad R, Siemionow Maria, Papay Francis, Pryor Landon, Gatherwright James, Kodish Eric, Paradis Carmen, Coffman Kathy, Mathes David, Schneeberger Stefan, Losee Joseph, Serletti Joseph M, Hivelin Mikaël, Lantieri Laurent, Zins James E
Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH 44195, USA.
Ann Plast Surg. 2009 Nov;63(5):572-8. doi: 10.1097/SAP.0b013e3181ba5245.
The objective of this review article is to summarize the published details and media citations for all seven face transplants performed to date to point out deficiencies in those reports so as to provide the basis for examining where the field of face transplantation stands, and to act as a stimulus to enhance the quality of future reports and functional outcomes. Overall long-term function of facial alloflaps has been reported satisfactorily in all seven cases. Sensory recovery ranges between 3 and 6 months, and acceptable motor recovery ranges between 9 and 12 months. The risks and benefits of facial composite tissue allotransplantation, which involves mandatory lifelong immunosuppression analogous to kidney transplants, should be deliberated by each institution's multidisciplinary face transplant team. Face transplantation has been shown thus far to be a viable option in some patients suffering severe facial deficits which are not amenable to modern-day reconstructive technique.
这篇综述文章的目的是总结迄今为止已公布的关于所有7例面部移植手术的详细信息和媒体报道,指出这些报告中的不足之处,以便为审视面部移植领域的现状提供依据,并激励提高未来报告的质量和功能结果。据报道,所有7例病例中面部异体皮瓣的整体长期功能均令人满意。感觉恢复在3至6个月之间,可接受的运动恢复在9至12个月之间。面部复合组织同种异体移植的风险和益处,这涉及到与肾移植类似的终身强制性免疫抑制,应由每个机构的多学科面部移植团队进行审议。到目前为止,面部移植已被证明是一些患有严重面部缺陷且无法通过现代重建技术治疗的患者的可行选择。